Balrampur Chini receives ₹75 Crore Government Grant

Balrampur Chini Mills Limited

has accepted a Rs 75 crore non-dilutive grant from BIRAC, under the Department of Biotechnology, to help fund a PLA Co-Polymer R&D facility in Uttar Pradesh. The R&D facility carries a total project cost of Rs 109.75 crore, with BIRAC's grant covering about 68% and the company funding the remaining Rs 34.75 crore. Shareholders approved acceptance at the 50th AGM on September 16, 2026. This sits alongside the larger commercial PLA bioplastics project, whose capex has been revised up to Rs 3,080 crore from Rs 2,850 crore. In Q1 FY27, consolidated revenue grew 6.12% year on year to Rs 1,636.79 crore, while net profit fell 14.4% to Rs 44.14 crore. What matters here is less the grant amount itself and more what it signals. Government funding covering roughly two-thirds of an R&D facility's cost is a real, non-dilutive validation of the PLA strategy, and it reduces the capital Balrampur Chini has to commit to prove out the technology before the much larger Rs 3,080 crore commercial plant scales up. The near-term numbers are a separate story. Net profit fell 14.4% even as revenue grew, attributed to sugar export restrictions, a reminder that the core sugar business still drives near-term earnings while PLA remains pre-revenue. I would not read this grant as an offset to that sugar segment pressure, the two are on different timelines entirely. I am watching construction progress on the R&D facility, the revised Rs 3,080 crore commercial PLA project's commissioning timeline in H2 FY27, and any easing in sugar export curbs that would relieve near-term earnings pressure. I am watching over a 3 to 12 month horizon as both R&D and commercial PLA milestones develop. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.